TAUCIFIC Trademark

Trademark Overview

On Thursday, November 25, 2021, a trademark application was filed for TAUCIFIC with the United States Patent and Trademark Office. The USPTO has given the TAUCIFIC trademark a serial number of 97143257. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, December 3, 2024. This trademark is owned by APRINOIA Therapeutics Inc.. The TAUCIFIC trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; imaging tracers, namely, diagnostic radiopharmaceutical agents for positron emission tomography (PET)

General Information

Serial Number97143257
Word MarkTAUCIFIC
Filing DateThursday, November 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, December 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Goods and ServicesDiagnostic preparations for medical purposes; diagnostic reagents and contrast media for medical use; contrast media for use with imaging medical equipment; imaging tracers, namely, diagnostic radiopharmaceutical agents for positron emission tomography (PET)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAPRINOIA Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 104-0033
JP
Party NameAPRINOIA Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 104-0033
JP

Trademark Events

Event DateEvent Description
Monday, November 29, 2021NEW APPLICATION ENTERED
Tuesday, November 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022ASSIGNED TO EXAMINER
Wednesday, September 14, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 14, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 14, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 6, 2023SOU EXTENSION 2 FILED
Wednesday, December 6, 2023SOU EXTENSION 2 GRANTED
Friday, December 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 3 GRANTED
Friday, March 3, 2023SOU EXTENSION 1 FILED
Friday, March 3, 2023SOU EXTENSION 1 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2024SOU EXTENSION 4 FILED
Tuesday, December 3, 2024SOU EXTENSION 4 GRANTED
Tuesday, June 4, 2024SOU EXTENSION 3 FILED

Related Keywords

taucific medical diagnostic media contrast imaging agents positron emission tomography radiopharmaceutical